MYRIAD GENETICS INC — Director's Dealing 2018

Jan 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-01-22

Reporting Person: King Gary A. (Exec. VP International Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-22	Common Stock	M	30000	$19.47	Acquired	151968	Direct
2018-01-22	Common Stock	S	30000	$39.77	Disposed	121968	Direct
2018-01-22	Common Stock	M	4445	$18.0	Acquired	126413	Direct
2018-01-22	Common Stock	S	4445	$39.03	Disposed	121968	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-22	Non-Qualified Stock Option (right to buy)	$18.0	M	4445	Disposed	2021-02-23	Common Stock (4445)	Direct
2018-01-22	Non-Qualified Stock Option (right to buy)	$19.47	M	30000	Disposed	2021-09-13	Common Stock (30000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.